Loading…
Based on limited metadata, ARG Laboratories, Inc., a drug manufacturer, received an FDA Warning Letter on June 11, 2024, though specific violation details are not available in the metadata provided. The letter falls under FDA's drug product regulatory authority, though the specific issuing office and detailed subject matter could not be determined from the available information. Without access to the full letter text, the precise nature of the compliance issues cannot be described. Companies receiving such warnings typically face citations for manufacturing, quality control, or labeling deficiencies that require prompt corrective action.